119 related articles for article (PubMed ID: 9095205)
1. Immunohistochemical evaluation of cathepsin D expression in colorectal cancer.
Mayer A; Fritz E; Fortelny R; Kofler K; Ludwig H
Cancer Invest; 1997; 15(2):106-10. PubMed ID: 9095205
[TBL] [Abstract][Full Text] [Related]
2. Tumour budding intensity in relation to cathepsin D expression and some clinicopathological features of colorectal cancer.
Famulski W; Guzińska-Ustymowicz K; Sulkowska M; Chabowski A; Zalewski B; Piotrowski Z; Stasiak-Barmuta A; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():171-2. PubMed ID: 11820592
[TBL] [Abstract][Full Text] [Related]
3. Cathepsin D content in colorectal cancer. Correlation with cathepsin D activity and other biological parameters: a preliminary report.
Tumminello FM; Gebbia N; Pizzolanti G; Russo A; Bazan V; Leto G
Oncology; 1995; 52(3):237-42. PubMed ID: 7715907
[TBL] [Abstract][Full Text] [Related]
4. CD44 expression in colorectal cancer. An immunohistochemical study including correlation with cathepsin D immunoreactivity and some tumour clinicopathological features.
Zalewski B; Famulski W; Sulkowska M; Sobaniec-Lotowska M; Piotrowski Z; Kisielewski W; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():152-3. PubMed ID: 11820582
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin D expression in colorectal adenocarcinomas and adenomas.
Kanber Y; Demirbag NR; Sam AD; Aydin N
Int J Biol Markers; 2002; 17(3):165-8. PubMed ID: 12408466
[TBL] [Abstract][Full Text] [Related]
6. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical evaluation of cathepsin D expression in colorectal tumours: a correlation with extracellular matrix components, p53, pRb, bcl-2, c-erbB-2, EGFR and proliferation indices.
Ioachim EE; Goussia AC; Machera M; Tsianos EV; Kappas AM; Agnantis NJ
Anticancer Res; 1999; 19(3A):2147-55. PubMed ID: 10470163
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of cathepsin D in colorectal tumors.
Arao J; Fukui H; Ono Y; Ueda Y; Chiba T; Fujimori T
Dis Colon Rectum; 2000 Mar; 43(3):396-401. PubMed ID: 10733123
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological significance of cathepsin D expression in gastric adenocarcinoma.
Ikeguchi M; Fukuda K; Oka S; Yamaguchi K; Hisamitsu K; Tsujitani S; Sakatani T; Ueda T; Kaibara N
Oncology; 2001; 61(1):71-8. PubMed ID: 11474252
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical expression of cathepsin D in colorectal cancer.
Valentini AM; Pirrelli M; Armentano R; Caruso ML
Anticancer Res; 1996; 16(1):77-80. PubMed ID: 8615673
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study.
Henry JA; McCarthy AL; Angus B; Westley BR; May FE; Nicholson S; Cairns J; Harris AL; Horne CH
Cancer; 1990 Jan; 65(2):265-71. PubMed ID: 2295049
[TBL] [Abstract][Full Text] [Related]
13. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas.
del Re EC; Shuja S; Cai J; Murnane MJ
Br J Cancer; 2000 Apr; 82(7):1317-26. PubMed ID: 10755408
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma. An immunohistochemical study.
Kristensen GB; Holm R; Abeler VM; Tropé CG
Cancer; 1996 Aug; 78(3):433-40. PubMed ID: 8697388
[TBL] [Abstract][Full Text] [Related]
15. Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
Ross JS; Nazeer T; Figge HL; Fisher HA; Rifkin MD
Am J Clin Pathol; 1995 Jul; 104(1):36-41. PubMed ID: 7541934
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas.
Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL
J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437
[TBL] [Abstract][Full Text] [Related]
17. The expression of multiple proteins as prognostic factors in colorectal cancer: cathepsin D, p53, COX-2, epidermal growth factor receptor, C-erbB-2, and Ki-67.
Shin IY; Sung NY; Lee YS; Kwon TS; Si Y; Lee YS; Oh ST; Lee IK
Gut Liver; 2014 Jan; 8(1):13-23. PubMed ID: 24516696
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer.
Kandalaft PL; Chang KL; Ahn CW; Traweek ST; Mehta P; Battifora H
Cancer; 1993 May; 71(9):2756-63. PubMed ID: 8385566
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin B, a prognostic indicator in lymph node-negative breast carcinoma patients: comparison with cathepsin D, cathepsin L, and other clinical indicators.
Lah TT; Cercek M; Blejec A; Kos J; Gorodetsky E; Somers R; Daskal I
Clin Cancer Res; 2000 Feb; 6(2):578-84. PubMed ID: 10690542
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor expression and metastatic potential of colorectal cancer.
Shigemori C; Wada H; Matsumoto K; Shiku H; Nakamura S; Suzuki H
Thromb Haemost; 1998 Dec; 80(6):894-8. PubMed ID: 9869156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]